Health

  • October 14, 2026

    Healthcare CEO Gets 19 Years In $450M Medicare Scheme

    A Florida federal judge sentenced a former healthcare executive Wednesday to 19 years in prison for running a $450 million scheme to swindle Medicare by using software that created false prescriptions for orthotic braces.

  • October 14, 2026

    Genesis Healthcare Gets Approval For Liquidation Plan

    A Texas bankruptcy judge Wednesday approved Genesis Healthcare's Chapter 11 liquidation plan after the nursing home operator secured the final signature it needed to close the $1 billion sale of its facilities.

  • October 14, 2026

    Couple Says Target Can't Escape Tainted Baby Formula Suit

    Two parents are urging a Washington federal court not to throw out their claims against Target Corp. in a suit alleging their baby contracted infant botulism from tainted baby formula sold at the store, saying their complaint sufficiently pleads that Target had a duty of reasonable care and should have looked into its sources.

  • October 14, 2026

    Sanofi Agrees Not To Disparage Rival's Flu Vaccine

    European enforcers have accepted commitments from Sanofi over concerns that it blocked competition from a rival flu vaccine for vulnerable patients by making disparaging statements to healthcare professionals in Germany and France.

  • October 14, 2026

    IRS Proposes To Block Immigrants From Premium Tax Credit

    Rules proposed Wednesday by the Internal Revenue Service would bar many immigrants from claiming the refundable tax credit for health insurance purchased through an exchange and impose new verification requirements for advance payments. 

  • October 14, 2026

    7-Eleven To Pay $2.3M To Resolve Tobacco Fee Fight

    7-Eleven Inc. will pay $2.3 million to settle a proposed class action alleging it violated federal benefits law by failing to let tobacco-using workers who completed a cessation program totally avoid a $720 annual health plan fee, according to a filing in Texas federal court.

  • October 13, 2026

    Liquidia Settles United Therapeutics Suits With $380.7M Deal

    Liquidia will pay out $380.7 million as part of a settlement agreement with United Therapeutics Corp. that resolves six lawsuits between the pharmaceutical companies, Liquidia announced Tuesday, saying patients will continue to have access to its Yutrepia lung disease treatment that was central to litigation.

  • October 13, 2026

    Skadden Adds 5 DLA Piper Mass Torts Attys To Chicago Office

    Skadden Arps Slate Meagher & Flom LLP continues to grow its mass torts and products liability litigation offerings in its Chicago office with the addition of five veteran litigators from DLA Piper, the firm announced on Tuesday.

  • October 13, 2026

    Feds' Mich. SNAP Records Fight Paused Pending Calif. Ruling

    A Michigan federal judge Tuesday paused the Trump administration's lawsuit that seeks to force Michigan into handing over certain Supplemental Nutrition Assistance Program applicant records, saying a California federal court overseeing the same "core legal issue" in a lawsuit filed by Michigan and other states should rule first.

  • October 13, 2026

    Mommy's Bliss Melatonin Isn't Safe For Kids, Suit Says

    Mommy's Bliss is improperly hawking its melatonin supplements as being suitable to treat children with insomnia or sleeplessness, despite numerous studies that say melatonin isn't safe for kids, as ingesting it has resulted in overdoses, hospitalizations and even death, alleges a proposed class action filed Monday in California federal court. 

  • October 13, 2026

    Island Golf Club And Hospital Sued After Wasp Sting Death

    A golf club and hospital on Martha's Vineyard face a widow's lawsuit claiming that they caused her 41-year-old husband's death after a wasp sting, saying the pesticide-free course failed to control the wasps' population and emergency responders misplaced the EpiPen that could have saved his life.

  • October 13, 2026

    Ex-U. Of Fla. Urologist Can't Get Sex Bias Suit Back On Track

    The Eleventh Circuit refused Tuesday to reinstate a lawsuit from a doctor who said gender discrimination got her removed from University of Florida's urology department, unpersuaded by her argument that a lower court prematurely shut down the bulk of her lawsuit.

  • October 13, 2026

    CVS Reaches $315M Deal With DOJ Over Opioid Prescriptions

    CVS Pharmacy Inc., the nation's largest pharmacy chain, has agreed to pay $315 million and implement certain safeguards to resolve claims that it knowingly filled invalid prescriptions for powerful opioids for years and sought payment through federal healthcare programs, the U.S. Department of Justice announced Tuesday.

  • October 13, 2026

    Denver Health Hit With Wage Suit Over Off-The-Clock Work

    Employees at a Denver medical network's call center aren't paid for all the time they work, a lawsuit filed in Colorado federal court Tuesday alleges, claiming the workers aren't fully compensated for the time they spend booting up their computers and logging in to nearly a dozen software programs.

  • October 13, 2026

    Justices Won't Review Arbitrator Bias In Nursing Home Suit

    The U.S. Supreme Court on Tuesday declined to review a Sixth Circuit decision upholding an arbitration award favoring a Kentucky nursing home, rejecting a request to clarify when an arbitrator's failure to disclose past misconduct warrants overturning an award.

  • October 13, 2026

    CarePoint Owes 401(k) Payments Post-Ch. 11, Union Says

    A healthcare workers union has accused CarePoint Health and operators that took over two of its New Jersey hospitals of failing to make 2024 retirement fund contributions under a settlement in the defunct nonprofit's Delaware bankruptcy case.

  • October 13, 2026

    Jones Day, Morgan Lewis Guide $2.1B Steris-Xodus Deal

    Steris PLC has agreed to acquire specialty surgical products business Xodus Medical Inc. and some affiliates for $2.1 billion, with Jones Day advising Steris and Morgan Lewis & Bockius LLP representing Xodus.

  • October 13, 2026

    Troutman Grows Life Sciences Litigation Group In Philly, NY

    A pair of attorneys specializing in healthcare and life sciences litigation recently moved their practices to Troutman Pepper Locke LLP's offices in Philadelphia and New York City.

  • October 13, 2026

    1st Circ. Revives Amgen Migraine Drug Risk Label Suit

    A mother in Massachusetts is entitled to pursue a new theory of liability against drugmaker Amgen Inc. over the death of her 25-year-old son after he took the company's then-recently approved migraine medication Aimovig in 2018, the First Circuit has found.

  • October 13, 2026

    Haynes Boone Launches In San Diego For 4th Calif. Location

    Haynes Boone has opened its first San Diego office to deepen its life sciences, healthcare and technology capabilities and has selected a co-chair of its biotechnology practice to lead its fourth workplace in California.

  • October 13, 2026

    Health Co. Mirra-Access Hits Ch. 11 To Deal With $400M Loan

    Healthcare company Mirra-Access is seeking Chapter 11 protection in a Florida bankruptcy court with more than $100 million in debt and plans to restructure a loan facility with a firm tied to Franklin Templeton.

  • October 13, 2026

    Dentons Adds K&L Gates Lawyer To Healthcare Practice In DC

    Dentons has hired a former K&L Gates LLP counsel as a partner in its Washington, D.C., office, where he will advise pharmaceutical, biotechnology and medical device companies on a range of matters related to regulatory and transactional oversight, the firm announced.

  • October 13, 2026

    McDermott Will Hires Ex-Greenberg RE Atty For NYC Office

    McDermott Will & Schulte has hired former Greenberg Traurig LLP real estate finance attorney Paul K. Kovachev to be a partner in its transactions practice group in New York City, the firm announced.

  • October 13, 2026

    Laid-Off Workers Can't Sue Amid Board Appeal, Feds Say

    The federal government asked a Maryland federal court to throw out a suit brought by more than 300 former federal workers who say their agency layoffs were politically motivated, arguing the workers must pursue their claims through an administrative process before heading to court.

  • October 09, 2026

    DOJ Aims To 'Attack Fraud From All Angles' Via New Division

    The U.S. Department of Justice's new fraud division has issued fresh guidance on its prosecution methodology, with the division's head directing prosecutors to seize assets before indictments and pursue upward variances in sentencing guidelines in some cases as part of a stated push to use the division's "full arsenal of criminal statutes" in combating fraud.

Expert Analysis

  • What Lawyers Should Know Before Accepting Crypto Payment

    Author Photo

    As clients increasingly request to pay legal fees, retainers and escrow funds using cryptocurrency, lawyers should consider how only a handful of state bar authorities have addressed the issue with varying ethics opinions, as well as the related questions that no authority has yet answered, says attorney Felix Shipkevich.

  • What To Know As State 'Neural Data' Privacy Laws Emerge

    Author Photo

    Attorneys at Goodwin discuss new state laws aimed at regulating consumer data generated from nervous system activity, explain why neurotechnology is attracting state and federal legislators’ attention, and highlight the compliance obligations that industry players should address now.

  • Health Plan Takeaways After 2nd Circ. No Surprises Act Ruling

    Author Photo

    While the Second Circuit's recent ruling in East Coast Advanced Plastic Surgery v. Cigna gives health plans breathing room in finding that healthcare providers cannot enforce out-of-network billing dispute resolution awards in court, sponsors should not assume that declining to pay awards will go unaddressed by regulators, say attorneys at Thompson Hine.

  • IDScan Data Breach Puts Spotlight On Vendor Oversight

    Author Photo

    A recently reported breach that exposed millions of identification documents held by IDScan.net highlights the liability risks for businesses that contract with third-party identity processors, and emphasizes the importance of auditing vendors' data retention practices, say attorneys at Tucker Ellis.

  • Series

    Mentalism Makes Me A Better Lawyer

    Author Photo

    Convincing strangers I can read their minds may seem like an unusual second career for a legal practitioner, but both disciplines share several important requirements, including trust and preparation, says Warren Biro at Manatt.

  • Why And How To Build A Neurodiversity-Informed Practice

    Author Photo

    By better understanding neurodiversity and implementing simple accommodations for clients with autism, ADHD or learning differences, attorneys can build stronger relationships with those who may otherwise struggle to obtain and benefit from legal services, while developing good habits that will benefit everyone they represent, says Ting Cheung at Sanford Heisler.

  • AG Watch: Texas Takes A Lone State Stand Against Tech Cos.

    Author Photo

    A look at Texas Attorney General Ken Paxton's recent actions against Meta Platforms and Amazon.com illustrates how Texas is distancing itself from multistate coordination, offering practitioners a crucial perspective on navigating individual state actions amid coordinated attorney general litigation, say attorneys at Kelley Drye.

  • Contact Lens Rule's Evolution Steers FTC Guidance Program

    Author Photo

    The history of the Federal Trade Commission's Contact Lens Rule illustrates the goals of the FTC's recently announced guidance program, which aims to strengthen consumer protection and safeguard competition, say attorneys at Wilson Sonsini.

  • Abbott FCA Deal Shows Enforcement Adequacy Quandaries

    Author Photo

    Abbott Laboratories’ recent False Claims Act resolution illustrates several tricky questions that both prosecutors and defense counsel must address when weighing whether a civil enforcement action alone adequately addresses allegedly wrongful conduct, says James Koukios at MoFo.

  • New DNA Screening Standard Has No Clear Playbook

    Author Photo

    Although the government has not yet released promised guidance intended to support its new standards for screening mail-order DNA, companies should not read this as a reprieve from the Oct. 13 compliance deadline because the delay shifts enforcement risk to statutes that need no new authority, including false statements, the False Claims Act and fraud, says Ashwin Ram at Buchalter.

  • Texas Medicaid Fraud Decision Leaves 2 Open Questions

    Author Photo

    The Texas Supreme Court's decision in Laboratory Corp. of America Holdings v. Texas and NPT Associates, holding that the Texas Medicaid Fraud Prevention Act's omissions provision requires proof of materiality, creates ambiguity about the materiality requirement and about how Texas courts will treat federal precedent going forward, say attorneys at Sidley.

  • Testing AI's Promise For Large-Scale Document Review

    Author Photo

    Our document-review comparison of attorneys' responsiveness and issue coding decisions versus predictions generated by artificial intelligence across 1,600 documents suggests that these tools can offer a reasonable and reliable basis for improved discovery workflows, provided lawyers understand where guardrails are needed, say attorneys at Redgrave.

  • 3rd Circ. Ruling Shows ADA Limits Amid Worker Misconduct

    Author Photo

    In Hileman v. West Penn Allegheny Health System, the Third Circuit recently rejected a wrongful termination claim under the Americans with Disabilities Act, illustrating that disability and leave laws don't automatically insulate employees from the consequences of prior workplace misconduct, say attorneys at Bond Schoeneck.

  • Navigating A Key Inflection Point In Biosimilar Sector M&A

    Author Photo

    As biosimilar mergers and acquisitions gain notice amid U.S. Food and Drug Administration reforms, a maturing patent framework and a looming patent cliff, companies diversifying into the higher-growth biologics space should align their regulatory, intellectual property and transactional strategies, say attorneys at Skadden.

  • AI Meeting Recaps Pose New Discovery And Privilege Risks

    Author Photo

    The New York City Bar Association’s recent ethics opinion, cautioning attorneys not to record nonclient conversations with artificial intelligence tools, reflects an emerging view that AI meeting recaps are now a distinct business record category, meaning counsel should set meeting-level controls and apply framework-level updates, says William Wright at Faegre Drinker.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here